XML 21 R11.htm IDEA: XBRL DOCUMENT v3.22.1
ACCRUED LIABILITIES
3 Months Ended
Mar. 31, 2022
Other Liabilities Disclosure [Abstract]  
ACCRUED LIABILITIES

NOTE 4 – ACCRUED LIABILITIES

 

Accrued liabilities as of March 31, 2022 and December 31, 2021 consist of the following (in thousands):

 

 

Schedule of Accrued Liabilities

      
   March 31, 2022  December 31, 2021
       
Accrued interest – third parties  $1,305   $1,420 
Accrued payroll   251    294 
Accrued residuals   28    98 
Anti-dilution provision       1,290 
Other   237    34 
Total accrued liabilities  $1,821   $3,136 

 

Accrued Interest

 

Notes payable and convertible notes payable incur interest at rates between 10% and 15%, per annum.

 

Accrued Residuals

 

The Company pays commissions to independent agents which refer merchant accounts. The amounts payable to these independent agents is based upon a percentage of the amounts processed on a monthly basis by these merchant accounts.

 

Anti-dilution provision

 

The agreement between the Company and Infinios, formerly NEC Payments B.S.C., has an anti-dilution provision. To remain in compliance, the Company accrued 73,848 shares of its common stock at $17.46 per share for a total value of $1.3 million as of December 31, 2021. Further, in connection with the capital raise discussed in Note 1, the Company accrued an additional 378,109 shares of its common stock at $2.20 per share for a value of $832 thousand or a total value of $2.1 million as of March 31, 2022. The 451,957 total shares were issued in May 2022, were classified as a long-term liability and treated as additional consideration to Infinios.